VAN

Visteon to Announce First Quarter 2024 Results on April 25

Retrieved on: 
Tuesday, April 9, 2024
VAN, Webcast, Visteon, News, Internet service provider

VAN BUREN TOWNSHIP, Mich., April 09, 2024 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, will release its first quarter 2024 financial results before the market opens on Thursday, April 25.

Key Points: 
  • VAN BUREN TOWNSHIP, Mich., April 09, 2024 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, will release its first quarter 2024 financial results before the market opens on Thursday, April 25.
  • The company will host a conference call for the investment community at 9 a.m.
  • The conference call is also available to the public via a live audio webcast .
  • Shortly after the call, a replay of the webcast will be available on the company’s website.

Visteon Announces 2023 Financial Results and 2024 Outlook

Retrieved on: 
Tuesday, February 20, 2024
Engineering, EV, OEM, Mahindra, European, Share repurchase, Digital, SUV, Growth, Electronics, VAN, Nissan Rogue, Visteon, Accounting, Nissan, Public expenditure, UAW

VAN BUREN TOWNSHIP, Mich., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Visteon Corporation (NASDAQ: VC) today reported fourth quarter and full-year 2023 financial results.

Key Points: 
  • VAN BUREN TOWNSHIP, Mich., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Visteon Corporation (NASDAQ: VC) today reported fourth quarter and full-year 2023 financial results.
  • Gross margin in the fourth quarter was $130 million, and net income attributable to Visteon was $366 million, or $12.98 per diluted share.
  • Visteon repurchased $106 million of shares during 2023 under the $300 million share repurchase authorization announced in March 2023.
  • "Visteon delivered another strong performance in 2023 with approximately $400 million of growth in our base sales.

ESI Expands into the B2B and Hospitality Markets

Retrieved on: 
Friday, March 8, 2024
ESI, B2B, VAN, EVP

VAN NUYS, Calif., March 7, 2024 /PRNewswire/ -- ESI, a global distributor, announces its expansion into the B2B and Hospitality Markets.

Key Points: 
  • VAN NUYS, Calif., March 7, 2024 /PRNewswire/ -- ESI, a global distributor, announces its expansion into the B2B and Hospitality Markets.
  • ESI works directly with manufacturers to distribute their products to Hotels, Casinos, Value Added Distributors (VAD's) and Employee Gifting Programs.
  • Tyler Asherian, ESI's EVP, stated, "As many companies are looking to decrease spending, ESI leverages our long-standing vendor relationships to offer pricing that provides our customers significant savings.
  • As brands struggle to offload their Excess or End-Of-Life Inventory, we found that distributing these products into the B2B market has positively impacted the brands' bottom lines as they are able to focus on their newer products instead of the previous generations."

Visteon to Announce Fourth Quarter and Full-Year 2023 Results on Feb. 20

Retrieved on: 
Wednesday, January 31, 2024
News, Webcast, VAN, Visteon, Internet service provider

VAN BUREN TOWNSHIP, Mich., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, will release its fourth quarter and full-year 2023 financial results before the market opens on Tuesday, Feb. 20.

Key Points: 
  • VAN BUREN TOWNSHIP, Mich., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, will release its fourth quarter and full-year 2023 financial results before the market opens on Tuesday, Feb. 20.
  • The company will host a conference call for the investment community at 9 a.m.
  • The conference call is also available to the public via a live audio webcast .
  • Shortly after the call, a replay of the webcast will be available on the company’s website.

LoanMart reports no discernable impact from end of student loan pause on title loan demand and payment performance

Retrieved on: 
Friday, February 2, 2024
Book, VAN, Security (finance)

With Q4 2023 in the books, LoanMart has taken an initial look at title loan payment performance and title loan demand for borrowers with vs. without student loans.

Key Points: 
  • With Q4 2023 in the books, LoanMart has taken an initial look at title loan payment performance and title loan demand for borrowers with vs. without student loans.
  • Thus far, the data does not show a material impact of the end of the student loan pause on the title loan borrowers.
  • Since the end of the student loan pause, the share of borrowers with outstanding student loan debt has accounted for only 21.2%, a reduction of 0.7%.
  • In summary, LoanMart's data thus far suggests that title loan customers with student loan debt have adjusted well to the end of the federal student loan pause.

Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures

Retrieved on: 
Wednesday, January 24, 2024
System, Death, Allergy, Heron, Patient, Vitamin, Naproxen, Elective surgery, SAN, Health, Partnership, Foot, Gastrointestinal bleeding, Ibuprofen, Vomiting, Anemia, Ankle, Stroke, Heart failure, Medicine, Nonsteroidal anti-inflammatory drug, Patient satisfaction, Cartilage, Risk, Meloxicam, Pain, VAN, Cross-link, Food, Constipation, Pregnancy, NDA, Anesthetic, Aspirin, Tears, FDA, Ulcer, Liver, Boxed warning, New Drug Application, Headache, Bupivacaine, Human, Blood, Pharmaceutical industry

SAN DIEGO, Jan. 23, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the U.S. Food and Drug Administration (the "FDA") has approved its supplemental New Drug Application ("NDA") for ZYNRELEF® (bupivacaine and meloxicam) extended-release solution to expand the indication for soft tissue and orthopedic surgical procedures including foot and ankle, and other procedures in which direct exposure to articular cartilage is avoided. ZYNRELEF was previously approved for foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures in adults.

Key Points: 
  • ZYNRELEF was previously approved for foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures in adults.
  • This expanded indication for ZYNRELEF will now cover an estimated 13 million procedures annually, an estimated increase of 86% over prior indicated procedures.
  • To obtain this labeling expansion, Heron successfully conducted studies for cesarean section, spinal surgery, augmentation mammoplasty, and total shoulder arthroplasty.
  • The most common side effects of ZYNRELEF are soft tissue procedures: vomiting and orthopedic procedures: constipation and headache.

U POWER Tech unveils "plug-and-play" EV chassis at CES; a tech and business model set to shake up the EV industry

Retrieved on: 
Wednesday, January 10, 2024
Silicon, Power, EVS, ZhenFund, Architecture, Renesas Electronics, Level 2, LAS, Matrix Partners, Multimedia, Partnership, AI, ADAS, UP, VAN, Investment, Today, Original equipment manufacturer, EV, CCV, Engine, CES, SUV, NVIDIA, LC2, Video game

U POWER delivers the first batch of UP Super Boards to Olympian Motors, a new-gen EV company headquartered in New York.

Key Points: 
  • U POWER delivers the first batch of UP Super Boards to Olympian Motors, a new-gen EV company headquartered in New York.
  • Leveraging its R&D capabilities and a business model that integrates the global EV industry supply chain, U POWER has announced partnership with business partners in Japan, Southeast Asia, Europe markets, with a goal of accelerating the EV industry transformation.
  • Showcasing an elevated class and refined aesthetic, the Olympian Model O1 is also on display at the U POWER CES booth.
  • Since 2021, U POWER has received investments from top dollar funds including Matrix Partners, CCV, ZhenFund and the leading auto industry funds Bosch's BOYUAN Capital.

Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain

Retrieved on: 
Sunday, January 7, 2024
Partnership, Heron, Meloxicam, SAN, Therapy, Spine, Growth, Bupivacaine, Patient, Cross-link, VAN, Nursing

The partnership will launch in several phases, initially at a regional level, followed by an expanded national rollout.

Key Points: 
  • The partnership will launch in several phases, initially at a regional level, followed by an expanded national rollout.
  • In total, approximately 650 representatives will be added to Heron's sales network over the next year.
  • CrossLink will be the lead partner in the United States to expand ZYNRELEF promotion for orthopedic indications.
  • "CrossLink has a proven track record of success in building relationships, providing superior service to healthcare providers and improving patient outcomes.

Visteon’s Deco Trim Command and Control Display Selected as CES 2024 Innovation Awards Honoree

Retrieved on: 
Thursday, November 16, 2023
Chicago Innovation Awards, CES, Engineering, Consumer Technology Association, Consumer Electronics Show, VAN, Control display unit, Visteon, Hand, Advanced Mobile Phone System, Paris Las Vegas, HVAC, Video game

VAN BUREN TOWNSHIP, Mich., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Visteon, a global technology company, announced today it was awarded a Consumer Electronics Show (CES) 2024 Innovation Award for its Deco Trim Command and Control Display. This is the second year in a row Visteon has been honored in the Vehicle Tech and Advanced Mobility category.

Key Points: 
  • VAN BUREN TOWNSHIP, Mich., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Visteon, a global technology company, announced today it was awarded a Consumer Electronics Show (CES) 2024 Innovation Award for its Deco Trim Command and Control Display.
  • This is the second year in a row Visteon has been honored in the Vehicle Tech and Advanced Mobility category.
  • The Deco Trim Command and Control Display enables a new level of design freedom, allowing automakers to eliminate bulky and unsightly buttons with a streamlined display that appears and disappears with the wave of a hand.
  • The award announcement was made ahead of CES 2024, the world's most influential technology event, on January 9-12 in Las Vegas.

BZAM to Acquire Final Bell's Canadian Operation, forming 5th Largest Canadian L.P.; Adding Final Bell Holdings International as Strategic Shareholder

Retrieved on: 
Wednesday, December 6, 2023
Acquisition, CSE, Transaction, FBC Bank, International, Cannabis, Agreement, VAN, FBC, Growth, Name, Good, Policy, Security (finance), Drug, Closing

"This Transaction combines BZAM's cultivation, production, and sales infrastructure with the exceptional portfolio of international brands that Final Bell has brought to market in Canada.

Key Points: 
  • "This Transaction combines BZAM's cultivation, production, and sales infrastructure with the exceptional portfolio of international brands that Final Bell has brought to market in Canada.
  • We are pleased to bring this team and these brands to BZAM," said Matt Milich, Chief Executive Officer of BZAM.
  • "This combination also brings in FBHI as an invaluable strategic shareholder to the Company, which creates additional opportunities for long term growth and value creation.
  • "(2)
    "This combination places the combined entity as the 5th largest Canadian L.P. on a proforma basis"(1)(2) said Robert Meyer, CEO of FBHI.